As of April 29, 2025, Leap Therapeutics (LPTX) has a market cap of $15.979 million USD. According to our data, Leap Therapeutics is ranked No.8652 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $15.98 M |
-85.50%
|
Dec 31, 2024 | $0.11 B |
-30.64%
|
Dec 29, 2023 | $0.16 B |
-7.89%
|
Dec 30, 2022 | $0.17 B |
-86.11%
|
Dec 31, 2021 | $1.24 B |
44.00%
|
Dec 31, 2020 | $0.86 B |
100.89%
|
Dec 31, 2019 | $0.43 B |
-44.00%
|
Dec 31, 2018 | $0.77 B |
-67.95%
|
Dec 29, 2017 | $2.39 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() MacroGenics
MGNX
|
$0.10 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Arcus Biosciences
RCUS
|
$0.86 B |
-0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.62 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.71 B |
-0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
Market Cap | = | LPTX Stock Price | * | LPTX Shares Outstanding |
= | $0.39 | * | 41.26 M | |
= | $15.98 M |